EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Exploring the therapeutic potential of monoclonal antibodies targeting TSLP and IgE in asthma management

Shuang Yan, Bowen Yang, Haichuan Qin, Chengzhen Du, Hua Liu, Tengchuan Jin

Inflammation Research · 2024

DOI: 10.1007/s00011-024-01908-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammation Research, 2024. Verfasst von Shuang Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan University of Arts and Science, DaZhou, 635000, China. oceanys0629@163.com. Hauptthemen laut MEDLINE: Asthma, Immunoglobulin E, Cytokines, Antibodies, Monoclonal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In recent years, there has been a growing interest in the utilization of biologic therapies for the management of asthma. Both TSLP and IgE are important immune molecules in the development of asthma, and they are involved in the occurrence and regulation of inflammatory response. METHODS: A comprehensive search of PubMed and Web of Science was conducted to gather information on anti-TSLP antibody and anti-IgE antibody. RESULTS: This investigation elucidates the distinct mechanistic roles of Thymic Stromal Lymphopoietin (TSLP) and Immunoglobulin E (IgE) in the pathogenesis of asthma, with a particular emphasis on delineating the therapeutic mechanisms and pharmacological properties of monoclonal antibodies targeting IgE and TSLP. Through a meticulous examination of clinical trials involving paradigmatic agents such as omalizumab and tezepelumab, we offer valuable insights into the potential treatment modalities for diseases with shared immunopathogenic pathways involving IgE and TSLP. CONCLUSION: The overarching objective of this comprehensive study is to delve into the latest advancements in asthma therapeutics and to provide guidance for future investigations in this domain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaImmunoglobulin ECytokinesAntibodies, MonoclonalThymic Stromal LymphopoietinAnti-Asthmatic AgentsHumansAnimalsOmalizumab

Stichwörter der Autor:innen

AntibodyAsthmaClinical trialsIgETSLP

Substanzen

Immunoglobulin ECytokinesAntibodies, MonoclonalThymic Stromal LymphopoietinAnti-Asthmatic AgentsOmalizumab

Autor:innen und Institutionen

  • Sichuan University of Arts and Science, DaZhou, 635000, China. oceanys0629@163.com.
  • Key Laboratory of Exploitation and Study of Distinctive Plants in Education Department of Sichuan Province, Sichuan Institute of Arts and Science, DaZhou, 635000, China. oceanys0629@163.com.
  • Key Laboratory of Green Chemistry of Sichuan Institutes of Higher Education, ZiGong, 643000, China. oceanys0629@163.com.
  • Unit for Drug and Instrument Supervision and Inspection of Wuxi Joint Logistic Support Center, Nanjing, 210000, China.
  • Sichuan University of Arts and Science, DaZhou, 635000, China.
  • Department of Obstetrics and Gynecology, Division of Life Sciences and Medicine, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, The First Affiliated Hospital of USTC, University of Science and Tec…

Zitieren

APA

Yan, S., Yang, B., Qin, H., Du, C., Liu, H., & Jin, T. (2024). Exploring the therapeutic potential of monoclonal antibodies targeting TSLP and IgE in asthma management. Inflammation Research. https://doi.org/10.1007/s00011-024-01908-2

Vancouver

Yan S, Yang B, Qin H, Du C, Liu H, Jin T. Exploring the therapeutic potential of monoclonal antibodies targeting TSLP and IgE in asthma management. Inflammation Research. 2024. doi:10.1007/s00011-024-01908-2

BibTeX
@article{Yan2024,
  author = {Yan, Shuang and Yang, Bowen and Qin, Haichuan and Du, Chengzhen and Liu, Hua and Jin, Tengchuan},
  title = {Exploring the therapeutic potential of monoclonal antibodies targeting TSLP and IgE in asthma management},
  journal = {Inflammation Research},
  year = {2024},
  doi = {10.1007/s00011-024-01908-2}
}
Kostenlos starten →